However, the expression of CEA and CA19-9 might be influenced by several factors, including the liver status, inflammation, and chemotherapy, limiting the precision of recurrence prognosis, especially in advanced-stage cancers [9,10]. This evidence concerns the gene CEACAM5 and cancer.